US chemical output slows, National Resilience consolidates operations, AstraZeneca partners with a Chinese firm, and more ...

Merck's Gardasil sales decline due to weak demand trends in China, with new launches expected to offset the downside.

AstraZeneca PLC closed 20.36% short of its 52-week high of £133.88, which the company achieved on September 3rd.

CSPC Pharmaceutical Group Ltd. announced June 13 that it struck a potential $5.33 billion deal with Astrazeneca plc to ...

Eli Lilly will acquire gene-editing startup Verve Therapeutics for up to $1.3 billion, the companies said on Tuesday, to ...

AstraZeneca PLC has acquired a significant stake of 15.86% in Niox Group PLC, according to a recent company filing. This move ...

(Reuters) -Drugmaker Eli Lilly is in advanced talks to acquire gene-editing startup Verve Therapeutics for up to $1.3 billion ...

An AI approach developed by researchers from the University of Sheffield and AstraZeneca, could make it easier to design ...

(NASDAQ:SRPT) plunged to $19.91, down $16.27, or almost 45%, on word of a second death by acute liver failure (ALF) with Elevidys (delandistrogene moxeparvovec), the approved gene therapy for patients ...

AstraZeneca PLC closed 19.20% below its 52-week high of £133.88, which the company achieved on September 3rd.

Scientists have developed a new machine learning framework that has shown the potential to be more accurate at inverse ...

Demand is rising for AI-powered robots that can clean offices or roll around moving items from one part of a building to ...